Biliary Stents Market Size, Share and Growth Outlook, 2026

Biliary Stents Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Biliary Stents Market size is forecast to increase from $175.92 Million in 2026 to $265.91 Million in 2034 at a CAGR of 5.3% between 2026 and 2034.

The Biliary Stents market report provides detailed analysis and outlook of Biliary Stents segments including By Product Type (Plastic Biliary Stents, Metal Biliary Stents ), By Procedure (Endoscopic Retrograde Cholangiopancreatography, Percutaneous Transhepatic Cholangiography ), By Application (Biliary Malignancy, Benign Biliary Strictures, Biliary Leaks), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Biliary Stents Industry Overview

Technological Advancements Driving the Evolution of Biliary Stent Therapies

The biliary stents industry is experiencing significant advancement as healthcare providers increasingly adopt sophisticated endoscopic solutions for the management of malignant and benign biliary obstructions. Rising incidence of pancreatic cancer, cholangiocarcinoma, gallstone-related strictures, and other hepatobiliary disorders is driving demand for durable and effective biliary drainage technologies. Manufacturers are focusing on improving stent patency, reducing complication rates, and enhancing procedural efficiency through innovative stent designs and advanced delivery systems. The market is increasingly characterized by the adoption of premium stent technologies that improve patient outcomes while reducing the need for repeat therapeutic interventions.

Growing Preference for Self-Expanding Metal Stents

A defining trend within the biliary stents industry is the growing preference for self-expanding metal stents (SEMS) over traditional plastic stents. Clinical practice patterns increasingly favor SEMS in both malignant biliary obstruction and complex benign biliary strictures due to their superior patency rates and reduced requirement for repeat endoscopic retrograde cholangiopancreatography (ERCP) procedures. Longer functional lifespan and improved biliary drainage performance have positioned self-expanding metal stents as the preferred option in many advanced hepatobiliary treatment settings. This shift is supporting greater utilization of high-performance stent technologies across tertiary care hospitals and specialized gastroenterology centers.

Innovation in Covered, Drug-Eluting, and Biodegradable Stent Technologies

Manufacturers are actively investing in next-generation stent designs to address limitations associated with conventional biliary drainage devices. Advanced fully covered and partially covered self-expanding metal stents are being developed to prevent tumor ingrowth while minimizing the risk of stent migration. In addition, biodegradable biliary stents and drug-eluting metal stents are progressing through clinical research and development programs. These emerging technologies aim to reduce restenosis, minimize inflammatory responses, and improve long-term biliary patency. Such innovations reflect the industry's commitment to enhancing therapeutic effectiveness and expanding treatment options for complex biliary disorders.

Value-Based Procurement Influencing Hospital Purchasing Decisions

Healthcare providers are increasingly adopting value-based procurement strategies that emphasize long-term clinical and economic outcomes. Hospitals and healthcare systems are prioritizing biliary stents that reduce overall treatment costs by minimizing the frequency of reinterventions and repeat endoscopic procedures. This trend has accelerated the adoption of premium radiopaque stents, precision-delivery systems, and advanced metal stent platforms in tertiary care institutions and multi-specialty healthcare facilities. As providers focus on improving efficiency and patient outcomes, demand continues to increase for high-performance biliary stent technologies capable of delivering durable clinical benefits while supporting cost-effective care delivery.

Biliary Stents Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Biliary Stents market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Boston Scientific Corporation, Cook Medical, Medtronic, Becton, Dickinson and Company (BD), Abbott Laboratories, Olympus Corporation, ConMed Corporation, Endo-Flex GmbH, M.I. Tech, Hobbs Medical, Inc.. The Biliary Stents market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Biliary Stents industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Biliary Stents Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Biliary Stents companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Biliary Stents markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Biliary Stents Market Competitive Benchmarking and Company Analysis

Leading companies in Biliary Stents industry include- Boston Scientific Corporation, Cook Medical, Medtronic, Becton, Dickinson and Company (BD), Abbott Laboratories, Olympus Corporation, ConMed Corporation, Endo-Flex GmbH, M.I. Tech, Hobbs Medical, Inc.. The Biliary Stents market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Biliary Stents Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Biliary Stents market remains one of the strongest-performing segments in the country.
The US Biliary Stents Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Biliary Stents market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Biliary Stents industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Biliary Stents markets

Canada's strong Biliary Stents sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Biliary Stents market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Biliary Stents Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Biliary Stents market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Biliary Stents population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Biliary Stents industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Biliary Stents market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Biliary Stents sales through 2034

France Biliary Stents companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Biliary Stents Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Biliary Stents distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Biliary Stents Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Biliary Stents market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Biliary Stents industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Biliary Stents industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Biliary Stents Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Biliary Stents market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Biliary Stents market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Biliary Stents Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Biliary Stents Market Segmentation

By Product Type
Plastic Biliary Stents
Metal Biliary Stents
By Procedure
Endoscopic Retrograde Cholangiopancreatography
Percutaneous Transhepatic Cholangiography
By Application
Biliary Malignancy
Benign Biliary Strictures
Biliary Leaks
By End-User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Top Companies in Biliary Stents Industry

Boston Scientific Corporation
Cook Medical
Medtronic
Becton, Dickinson and Company (BD)
Abbott Laboratories
Olympus Corporation
ConMed Corporation
Endo-Flex GmbH
M.I. Tech
Hobbs Medical, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025